Lupin share price traded under selling pressure in Wednesday's trade to quote at Rs 2,230.60 per share on the NSE, down 1.75 ...

Lupin has entered into a patent license agreement with Takeda to commercialise Vonoprazan tablets, a novel gastrointestinal ...

Lupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialize Vonoprazan tablets ...

A common diabetes medication, metformin, slows the growth of precancerous cells in the esophagus while some metabolic ...

Certain drug classes contain caustic ingredients that damage the soft, delicate lining of the esophagus. More specifically, they cause "inflammation or an erosion of the esophageal lining, resulting ...

Do not administer concomitantly with any other medications through same IV site and/or tubing. GERD with erosive esophagitis: Adults: Give by IV inj (no less than 3 mins) or IV infusion (10–30 ...

Serum chromogranin A (CgA) levels increase secondary to drug-induced decreases in gastric ... Patients with acute endoscopically proven reflux esophagitis with at least 1 of 3 symptoms typical ...

Eosinophilic esophagitis (EoE) is an allergic inflammatory disorder that affects the esophagus, causing distressing symptoms such as difficulty swallowing in adolescents and adults, and vomiting ...

Fangyu Zhang, 34, engineered single-cell, self-propelled microalgae into a swarm of swimming biorobots that can be used to ...

“The EsoCap novel smart drug delivery technology will enable targeted and long-lasting local therapy of the esophagus for the first time,” said Isabelle Racamier, EsoCap CEO. “We carried out ...

CALY-002 is under development for the treatment of eosinophilic esophagitis, celiac disease and unspecified dermatological disorders. It is a fully-humanized monoclonal antibody also administered ...

Background: Gastroesophageal reflux occurs mainly during the daytime in patients with Los Angeles grade A esophagitis, but predominantly during the night in patients with grade C and D esophagitis.